Company Filing History:
Years Active: 1985
Title: The Innovations of Johannes-Maximilian Weisenberger
Introduction
Johannes-Maximilian Weisenberger is a notable inventor based in Biberach, Germany. He has made significant contributions to the field of pharmaceuticals, particularly through his innovative work on benzoxazin-2-ones. His dedication to research and development has led to advancements that may benefit various medical applications.
Latest Patents
Weisenberger holds a patent for "Substituted benzoxazin-2-ones and pharmaceutical compositions containing." This invention is directed to novel benzoxazin-2-ones of the formula ##STR1## wherein A is a sulfur atom or an SO, SO₂, R--N≡S, or R--N≡SO₂ group where R is a hydrogen atom or an acyl group. This patent represents a significant step forward in the development of pharmaceutical compositions.
Career Highlights
Weisenberger is currently employed at Dr. Karl Thomae GmbH, a company known for its commitment to pharmaceutical innovation. His work at the company has allowed him to explore new avenues in drug development and contribute to the advancement of medical science.
Collaborations
Throughout his career, Weisenberger has collaborated with esteemed colleagues such as Berthold Narr and Josef Nickl. These partnerships have fostered a collaborative environment that encourages innovation and the sharing of ideas.
Conclusion
Johannes-Maximilian Weisenberger's contributions to the field of pharmaceuticals through his patent on benzoxazin-2-ones highlight his role as a significant inventor. His work continues to pave the way for future advancements in medical treatments.
Inventor’s Patent Attorneys refers to legal professionals with specialized expertise in representing inventors throughout the patent process. These attorneys assist inventors in navigating the complexities of patent law, including filing patent applications, conducting patent searches, and protecting intellectual property rights. They play a crucial role in helping inventors secure patents for their innovative creations.